Barely Significant
← all excerpts

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.

BMC Med · 2011 · PMC3038965 · PMID 21281463

Europe PMCDOI
1
hedged sentence
0.0090
closest p · 0.2× alpha
0.0090
boldest claim

The sentences

highly significantP = 0.009actually significant
On the other hand, in this study after adjustment for imbalances in the TNM status between treatment groups, a multivariate analysis "rendered" a statistically significant DFS advantage in favor of the irinotecan arm ( P = 0.021), while a highly significant relapse-free survival advantage for the same arm could be achieved ( P = 0.009) [ 21 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.